logo

PHGE

BiomX·AMEX
--
--(--)
--
--(--)
4.19 / 10
Netural

PHGE's fundamentals are moderate with a 4.2/10 score. Key positives include a healthy interest-coverage ratio (15.48) and strong YoY revenue growth (92.66% operating revenue). However, elevated days-sales-outstanding (72.55) and negative asset-MV (-0.50) raise concerns. Net income and cash flow metrics are neutral, suggesting the company is financially stable but not exceptional. Overall, the balance sheet and profitability are adequate but not compelling.

Fundamental(4.19)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.26
Score3/3
Weight20.17%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.72%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.22%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight16.08%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.10%
1M Return8.45%
PB-ROE
Value-0.56
Score3/3
Weight21.80%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.61%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.66%
1M Return0.43%
Asset-MV
Value-0.50
Score0/3
Weight11.48%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight15.81%
1M Return8.41%
Is PHGE undervalued or overvalued?
  • PHGE scores 4.19/10 on fundamentals and holds a Fair valuation at present. Backed by its -132.02% ROE, 0.00% net margin, -0.32 P/E ratio, 0.57 P/B ratio, and -1346.90% earnings growth, these metrics solidify its Netural investment rating.